Company profile: Tenaya Therapeutics
1.1 - Company Overview
Company description
- Provider of clinical-stage gene and small molecule therapies for heart diseases, including TN-201 for MYBPC3-associated hypertrophic cardiomyopathy, TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, and TN-301, an HDAC6 inhibitor for heart failure with preserved ejection fraction.
Products and services
- TN-201 for MYBPC3-associated HCM: Gene-therapy product delivering a functional MYBPC3 gene to heart muscle cells to treat hypertrophic cardiomyopathy
- TN-301 for Heart Failure with Preserved Ejection Fraction (HFpEF): HDAC6-selective small-molecule therapy intended to improve cardiac function and reduce fibrosis in HFpEF through HDAC6 inhibition
- TN-401 for PKP2-associated ARVC: Gene-therapy product introducing a working PKP2 gene into the heart to restore healthy function and halt disease progression in arrhythmogenic right ventricular cardiomyopathy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tenaya Therapeutics
Cordis
HQ: United States
Website
- Description: Provider of less invasive treatments for vascular disease as a Johnson & Johnson company, and developer/manufacturer of stents, catheters, and guidewires. Offerings include SELUTION SLR Drug-Eluting Balloon for controlled, sustained sirolimus release; BRITE TIP Guiding Catheter; MYNX CONTROL Vascular Closure Device; RAIN Sheath Transradial thin-walled introducer; and RAILWAY Sheathless Access System.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cordis company profile →
Capstan Medical
HQ: United States
Website
- Description: Provider of minimally invasive catheter-based technologies for heart valve disorders, including the Capstan Platform for treating mitral and tricuspid valve disease while the heart is beating, precision heart valve implants placed through a catheter, and surgical robotics integration to enhance procedure accuracy and reliability, offering a less invasive alternative to open heart surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capstan Medical company profile →
CardioNexion Health
HQ: France
Website
- Description: Provider of custom medical monitoring solutions for cardiovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioNexion Health company profile →
AtheroMed
HQ: United States
Website
- Description: Provider of peripheral atherectomy catheter systems to enhance treatment of below-the-knee disease; develops treatments for peripheral arterial disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AtheroMed company profile →
PLC Medical Systems
HQ: United States
Website
- Description: Provider of health care solutions as a Health Care company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PLC Medical Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tenaya Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tenaya Therapeutics
2.2 - Growth funds investing in similar companies to Tenaya Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tenaya Therapeutics
4.2 - Public trading comparable groups for Tenaya Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →